Literature DB >> 3737

Correction of severe combined immunodeficiency by fetal liver cells.

R H Buckley, K J Whisnant, R I Schiff, R B Gilbertsen, A T Huang, M S Platt.   

Abstract

As an alternative to bone-marrow transplantation, two infants with severe combined immunodeficiency who had no histocompatible donors were given intraperitoneal infusions of fresh liver cells from fetuses of eight and nine to 10 weeks. Transient graft-versus-host disease began at 42 and 52 days, respectively. Both infants had rises in T cells and declines in B cells by three months. No functional immunologic improvement occurred in the first infant, who died of pulmonary disease 10 months later. Clinical and functional immunologic improvement occurred in the other, who is now 19 months after transplantation. Lymphocyte responses to phytohemagglutinin and pokeweed mitogen were noted by three months, to concanavalin A by five months, and to allogeneic cells by eight months. Delayed cutaneous responsiveness to candida developed and IgM became norma. IgA and IgG remained low. Chimerism was demonstrated by a donor marker chromosome in metaphases from recipient lymphocytes. Fetal liver cells therefore reversed the immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 3737     DOI: 10.1056/NEJM197605132942002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

1.  Transplantation of fetal liver cells in the treatment of severe combined immunodeficiency disease.

Authors:  B Löwenberg; J M Vossen; L J Dooren
Journal:  Blut       Date:  1977-03

Review 2.  Fetal stem cell transplantation: Past, present, and future.

Authors:  Tetsuya Ishii; Koji Eto
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

3.  Modulatory effects on immunoglobulin synthesis and secretion by lymphocytes from immunodeficient patients.

Authors:  S A Schwartz; Y S Choi; L Shou; R A Good
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

4.  Extraneous HLA antigens in severe combined immunodeficiency disease (scid). Survey of the literature and report of one new case.

Authors:  K G Evers; J Krüger; R Hägele
Journal:  Eur J Pediatr       Date:  1977-04-26       Impact factor: 3.183

Review 5.  Stem cell transplantation.

Authors:  K Hajdu; M S Golbus
Journal:  West J Med       Date:  1993-09

Review 6.  Conception and development of the fetal tissue bank.

Authors:  S D Lawler
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

7.  Treatment of severe combined immunodeficiency by transplantation.

Authors:  D Niethammer
Journal:  Blut       Date:  1981-03

8.  Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect.

Authors:  R H Buckley; R B Gilbertsen; R I Schiff; E Ferreira; S O Sanal; T A Waldmann
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

10.  Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency.

Authors:  R Pahwa; S Pahwa; R A Good; G S Incefy; R J O'Reilly
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.